Recurrence‐free interval 12 months after local treatment of mast cell tumors in dogs using intratumoral injection of tigilanol tiglate

BACKGROUND: Tigilanol tiglate (TT) is a novel small molecule approved by the European Medicines Agency for intratumoral treatment of mast cell tumors (MCTs) in dogs. In a randomized controlled clinical efficacy and safety study in the United States, 85 of 116 dogs that received a single TT injection...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Vet Intern Med
Main Authors: Jones, Pamela D., Campbell, Justine E., Brown, Graham, Johannes, Chad M., Reddell, Paul
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley & Sons, Inc. 2020
Fag:
SMALL ANIMAL
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7848364/
https://ncbi.nlm.nih.gov/pubmed/33350511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.16018
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker